Insider trades
Michelle Robertson, Director of Verastem VSTM, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $19.1K. The latest trade was on 05/21.
Michelle Robertson
Director
- Company
- Verastem VSTM
- First filing
- 23/01/12
- Trades
- 23 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$19.1K
- Last trade
- 05/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
GeronGERN | Open-market sale | 02/18 | 02/19 | 9,855 sh | $1.94 | $19,118.7 | −35.8% |
Editas MedicineEDIT | Open-market sale10b5-1 plan | 23/05/11 | 23/05/15 | 949 sh | $9.87 | $9,366.63 | −0.9% |
Editas MedicineEDIT | Open-market sale | 23/03/03 | 23/03/06 | 184 sh | $8.89 | $1,635.76 | −0.2% |
Editas MedicineEDIT | Open-market sale | 23/02/13 | 23/02/15 | 4,287 sh | $9.67 | $41,455.29 | −5.3% |
Editas MedicineEDIT | Open-market sale | 23/01/10 | 23/01/12 | 1,752 sh | $8.16 | $14,296.32 | −2.1% |